EndoSpan Ltd.

www.endospan.com

Now EndoSpan (an Artivion company)

High-Tech Company

Acquired by Artivion

TECH VERTICALS

Biotechnology, Cardiovascular, Healthtech, Implants, Life Sciences, Medical Devices, MedTech, Stents

General Data

Sector	Medical Devices
Company Stage:	Initial Revenues
Established	2009
Number of Employees	60
Employees in Israel	50

DESCRIPTION

Endospan is a pioneer in the endovascular repair of aortic arch disease including aneurysms and dissections. Endospan has received CE-Mark to commercialize in Europe the NEXUS Stent Graft System, the first endovascular off-the-shelf system to treat Aortic Arch Disease which affects a greatly underserved group of patients diagnosed with a dilative lesion in, or near, the aortic arch. While minimally invasive endovascular repair has been the standard of care for Abdominal Aortic Aneurysm (AAA), Aortic Arch Disease patients with aneurysms or dissections have not been as fortunate and have had little choice but to undergo open-chest surgery with its invasiveness and risks, lengthy hospitalization periods, and prolonged recuperation.

TECHNOLOGY

NEXUS® multi-branched/modular aortic arch stent graft system.

Products and Phases

Product	Phase
NEXUS™	FDA Approved CE Approved
NEXUS is an endovascular aortic arch stent graft system, designed to support minimally invasive treatment of aortic arch disease such as aneurysms and dissections. The device uses a branched modular design to enable repair of complex arch anatomy while reducing the need for open surgical procedures.

ESTIMATED ANNUAL SALES

	TARGET MARKETS
	Cardiovascular and vascular surgery providers treating aortic arch aneurysms, dissections, and related pathologies.

	BUSINESS MODEL
	B2C

COMPETITORS

Concept Medical , Aptusendo , AngioScore

CONTACT INFO

Expand / Collapse All

Main Address: Herzliya, Israel

Address	4 Maskit St.
POB	12058
City	Herzliya
Country	Israel
Zip	4673334

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title
Mr. Rafi Benary	Co-Founder
Mr. Alon Shalev	Co-Founder

Mergers & Acquisitions

Round

Date

Stage

Amount

Valuation

Acquired

May. 18, 2026

Initial Revenues

abCDe

	FINANCIAL ROUNDS

Total Capital Raised
abCDe

Financial Rounds

Numbers of Investors

Expand / Collapse All

Round

Date

Stage

Amount

Valuation

Debt Financing

Jul. 01, 2024

Initial Revenues

abCDe

Debt Financing

Oct. 01, 2019

Initial Revenues

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	High-Tech Company	abCDe	Artivion (formerly CryoLife) has entered into distribution and credit facility (up to $15m) agreements with Endospan, as well as an option agreement to purchase Endospan.

Fifth Round

Oct. 01, 2019

Initial Revenues

abCDe

Fourth Round

Oct. 21, 2015

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Corporate VC	abCDe	Led the round
abC Defghij	Investment Company	abCDe
abC Defghij	Private Investor	abCDe

Third Round

Mar. 01, 2013

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe	Led the round
abC Defghij	Investment Company	abCDe
abC Defghij	Private Investor	abCDe

Second Round

Sep. 13, 2011

R&D

abCDe

First Round

Oct. 01, 2009

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe	Led the round
abC Defghij	Private Investor	abCDe

Seed

Mar. 01, 2009

Seed

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Holding Company	abCDe
abC Defghij	Technology Transfer Company	abCDe
abC Defghij	Private Investor	abCDe
abC Defghij	Private Investor	abCDe

Last Updated:	abCDe
IVC Number:	abCDe